Occurrence of low frequency PIK3CA and AKT2 mutations in gastric cancer

Qing-Ying Zhang1, Wen-Xiang Cheng2, Wen-Mei Li3

  • 1Department of Preventive Medicine, Shantou University Medical College, Shantou 515041, China.

Mutation Research
|March 17, 2015
PubMed

Insights

Mutations in PIK3CA and AKT2 genes, crucial for cancer development, were infrequent in Chinese gastric cancer (GC) patients. These findings suggest other factors are involved in gastric carcinogenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The PI3K/AKT pathway is vital in tumor progression, with PIK3CA mutations common in various cancers.
  • While AKT2 activation is studied in cancer, its mutation frequency is less reported.
  • PIK3CA and AKT2 mutations are implicated in carcinogenesis.

Purpose of the Study:

  • To determine the mutation frequencies of PIK3CA and AKT2 in gastric cancer (GC) in China.
  • To investigate the involvement of these genes in gastric carcinogenesis.

Main Methods:

  • Screening of hot-spot exons (9, 18, 20) of PIK3CA and kinase domain exons (6-14) of AKT2.
  • Analysis of 10 GC cell lines and 100 primary GC tissues with matched normal samples.
  • Utilized Denaturing High Performance Liquid Chromatography (DHPLC) and DNA sequencing.

Main Results:

  • PIK3CA mutations were found in 4/10 GC cell lines and 4/100 primary GC tumors.
  • AKT2 mutations were identified in 1/10 GC cell lines and 3/100 primary GC tumors.
  • AKT2 polymorphisms were detected in 19/100 primary GC tumors, with no hot-spot variations.

Conclusions:

  • PIK3CA and AKT2 mutations occur at a low frequency in Chinese gastric cancer.
  • The PI3K/AKT2 pathway may involve other mechanisms in gastric carcinogenesis.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.4K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.7K